References
- Al-Hajj M, Wicha MS, Benito-Hernandez A, et al (2003). Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA, 100, 3983-8. https://doi.org/10.1073/pnas.0530291100
- Alvi AJ, Clayton H, Joshi C, et al (2003). Functional and molecular characterisation of mammary side population cells. Breast Cancer Res, 5, 1-8. https://doi.org/10.1186/bcr660
- Campbell LL and Polyak K (2007). Breast tumor heterogeneity: cancer stem cells or clonal evolution? Cell Cycle, 6, 2332-8. https://doi.org/10.4161/cc.6.19.4914
- Chen CY, Chiou SH, Huang CY, et al (2009). Distinct population of highly malignant cells in a head and neck squamous cell carcinoma cell line established by xenograft model. J Biomed Sci, 16, 100. https://doi.org/10.1186/1423-0127-16-100
- Cianfrocca M and Goldstein LJ (2004). Prognostic and predictive factors in early-stage breast cancer. Oncologist, 9, 606-16. https://doi.org/10.1634/theoncologist.9-6-606
- Clayton H, Titley I and Vivanco M (2004). Growth and differentiation of progenitor/stem cells derived from the human mammary gland. Exp Cell Res, 297, 444-60. https://doi.org/10.1016/j.yexcr.2004.03.029
- Croker AK, Goodale D, Chu J, et al (2009). High aldehyde dehydrogenase and expression of cancer stem cell markers selects for breast cancer cells with enhanced malignant and metastatic ability. J Cell Mol Med, 13, 2236-52. https://doi.org/10.1111/j.1582-4934.2008.00455.x
- Engelmann K, Shen H and Finn OJ (2008). MCF7 side population cells with characteristics of cancer stem/ progenitor cells express the tumor antigen MUC1. Cancer Res, 68, 2419-26. https://doi.org/10.1158/0008-5472.CAN-07-2249
- Fuchs D, Heinold A, Opelz G, et al (2009). Salinomycin induces apoptosis and overcomes apoptosis resistance in human cancer cells. Biochem Biophys Res Commun, 390, 743-9. https://doi.org/10.1016/j.bbrc.2009.10.042
- Goodell MA, Brose K, Paradis G, et al (1996). Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo. J Exp Med, 183, 1797-806. https://doi.org/10.1084/jem.183.4.1797
- Han JS and Crowe DL (2009). Tumor initiating cancer stem cells from human breast cancer cell lines. Int J Oncol, 34, 1449-53.
- Jatoi I, Hilsenbeck SG, Clark GM, et al (1999). Significance of axillary lymph node metastasis in primary breast cancer. J Clin Oncol, 17, 2334-40.
-
Kabashima A, Higuchi H, Takaishi H, et al (2009). Side population of pancreatic cancer cells predominates in TGF-
$\beta$ -mediated epithelial to mesenchymal transition and invasion. Int J Cancer, 124, 2771-9. https://doi.org/10.1002/ijc.24349 - Kato K, Yoshimoto M, Kato K, et al (2007). Characterization of side-population cells in human normal endometrium. Hum Reprod, 22, 1214-23. https://doi.org/10.1093/humrep/del514
- Kusama S, Spratt JS, Donegan WL, et al (1972). The gross rates of growth of human mammary carcinoma. Cancer, 30, 594-9. https://doi.org/10.1002/1097-0142(197208)30:2<594::AID-CNCR2820300241>3.0.CO;2-2
- Mimeault M, Hauke R, Mehta PP, et al (2007). Recent advances in cancerstem/progenitor cell research: therapeutic implications for overcomingresistance to the most aggressive cancers. J Cell Mol Med, 11, 981-1011. https://doi.org/10.1111/j.1582-4934.2007.00088.x
- Mitsutake N, Iwao A, Nagai K, et al (2007). Characterization of side population in thyroid cancer cell lines: Cancer stem-like cells are enriched partly but not exclusively. Endocrinology, 148, 1797-803. https://doi.org/10.1210/en.2006-1553
- Nakanishi T, Chumsri S, Khakpour N, et al (2010). Sidepopulation cells in luminal-type breast cancer have tumour-initiating cell properties, and are regulated by HER2 expression and signalling. Br J Cancer, 102, 815-26. https://doi.org/10.1038/sj.bjc.6605553
- Nishii T, Yashiro M, Shinto O, et al (2009). Cancer stem cell-like SP cells have a high adhesion ability to the peritoneum in gastric carcinoma. Cancer Sci, 100, 1397-402. https://doi.org/10.1111/j.1349-7006.2009.01211.x
- Nogami T, Shien T, Tanaka T, et al (2014). Expression of ALDH1 in axillary lymph node metastases is a prognostic factor of poor clinical outcome in breast cancer patients with 1-3 lymph node metastases. Breast Cancer, 21, 58-65. https://doi.org/10.1007/s12282-012-0350-5
- Patrawala, L., Calhoun T, R. Schneider-Broussard, et al (2005). Side population is enriched in tumorigenic, stem-like cancer cells, whereas ABCG2+ and ABCG2- cancer cells are similarly tumorigenic. Cancer Res, 65, 6207-19. https://doi.org/10.1158/0008-5472.CAN-05-0592
- Ponti D, Costa A, Zaffaroni N, et al (2005). Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties. Cancer Res, 65, 5506-11. https://doi.org/10.1158/0008-5472.CAN-05-0626
- Raaijmakers MH (2007). ATP-binding-cassette transporters in hematopoieticstem cells and their utility as therapeutical targets in acute and chronicmyeloid leukemia. Leukemia, 21, 2094-02. https://doi.org/10.1038/sj.leu.2404859
- Reya T, Morrison SJ, Clarke MF, et al (2001). Stem cells, cancer, and cancer stem cells. Nature, 414, 105-11. https://doi.org/10.1038/35102167
- Rosa Mendoza ES, Moreno E and Caguioa PB (2013). Predictors of early distant metastasis in women with breast cancer. J Cancer Res Clin Oncol, 139, 645-52. https://doi.org/10.1007/s00432-012-1367-z
- Sakariassen PO, Immervoll H, Chekenya M (2007). Cancer stem cells as mediators of treatment resistance in brain tumors : status and controversies. Neoplasia, 9, 882-92. https://doi.org/10.1593/neo.07658
- Sankaranarayanan R, Swaminathan R, Lucas E (2011). Cancer survival in Africa, Asia, the Caribbean and Central America (SurvCan). IARC scientific publications volume 162, ISBN 978-92-832-2162-3, Lyon, International Agency for Research on Cancer.
- Song J, Chang I, Chen Z, et al (2010). Characterization of side populations in hnscc: highly invasive, chemoresistant and abnormal wnt signaling. PLoS One, 5, 11456. https://doi.org/10.1371/journal.pone.0011456
- Steiniger SC, Coppinger JA, Kruger JA, et al (2008). Quantitative mass spectrometry identifies drug targets in cancer stem cell containing side population. Stem Cells, 26, 3037-46. https://doi.org/10.1634/stemcells.2008-0397
- Sun Y, Liao M, Cheng G (2011). NCCN non-small cell lung cancer clinical practice guideline: Chinese Edition Version 2011. Beijing.
- Van den Broeck A, Vankelecom H, Van DelmW, et al (2013). Human pancreatic cancer contains a side population expressing cancer stem cell-associated and prognostic genes. PloS One, 8, 73968. https://doi.org/10.1371/journal.pone.0073968
- Visvader JE, Lindeman GJ (2008). Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. Nat Rev Cancer, 8, 755-68. https://doi.org/10.1038/nrc2499
- Weigel MT, Dowsett M (2010). Current and emerging biomarkers in breast cancer: prognosis and prediction. Endocr Relat Cancer, 17, 245-62. https://doi.org/10.1677/ERC-10-0136
- Woodward WA, Chen MS, Behbod F, et al (2007). WNT/betacatenin mediates radiation resistance of mouse mammary progenitor cells. Proc Natl Acad Sci USA, 104, 618-23. https://doi.org/10.1073/pnas.0606599104
- Wu C and Alman BA. (2008) Side population cells in human cancers. Cancer Lett, 268, 1-9. https://doi.org/10.1016/j.canlet.2008.03.048
- Yang M, Zhang R, Yan M, et al (2010). Detection and characterization of side population in Ewing's sarcoma SK-ES-1 cells in vitro. Biochem Biophys Res Commun, 391, 1062-6. https://doi.org/10.1016/j.bbrc.2009.12.020
- Yin L, Castagnino P, Assoian RK (2008). ABCG2 Expression and side population abundance regulated by a transforming growth factor {beta}-directed epithelial-mesenchymal transition. Cancer Res, 68, 800-7. https://doi.org/10.1158/0008-5472.CAN-07-2545
- Zeppernick F, Ahmadi R, Campos B, et al (2008). Stem cell markercd133 affects clinical outcome in glioma patients. Clin Cancer Res, 14, 123-9. https://doi.org/10.1158/1078-0432.CCR-07-0932
- Zhang AM, Fan Y, Yao Q, Ma H, et al (2012). Identification of a cancer stem-like population in the Lewis lung cancer cell line. Asian Pac J Cancer Prev, 13, 761-6. https://doi.org/10.7314/APJCP.2012.13.3.761
- Zhou J, Zhang H, Gu P, et al (2008). Cancer stem/progenitor cell active compound 8-quinolinol in combination with paclitaxel achieves an improved cure of breast cancer in the mouse model. Breast Cancer Res Treat, 115, 269-77.
Cited by
- Do Different Stemness Markers Identify Different Pools of Cancer Stem Cells in Malignancies: A Study on ER+ and ER-Breast Cancer Cell Lines pp.1532-2807, 2018, https://doi.org/10.1007/s12253-018-0503-8